TITLE

Findings May Lead to Better Vaccine for Respiratory Syncytial Virus

AUTHOR(S)
Hampton, Tracy
PUB. DATE
December 2013
SOURCE
JAMA: Journal of the American Medical Association;12/11/2013, Vol. 310 Issue 22, p2389
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the development of an experimental vaccine against respiratory syncytial virus (RSV) due to findings of studies involving a protein that resides in the membrane of the virus.
ACCESSION #
92885200

 

Related Articles

  • Safety and Immunogenicity of a Novel Recombinant Subunit Respiratory Syncytial Virus Vaccine (BBG2Na) in Healthy Young Adults. Power, Ultan F.; Nguyen, Thien N.; Rietveld, Edwin; de Swart, Rik L.; Groen, Jan; Osterhaus, Albert D.M.E.; de Groot, Ronald; Corvaia, Nathalie; Beck, Alain; Bouveret-le-Cam, Nancy; Bonnefoy, Jean-Yves // Journal of Infectious Diseases;12/1/2001, Vol. 184 Issue 11, p1456 

    A novel recombinant respiratory syncytial virus (RSV) subunit vaccine, designated BBG2Na, was administered to 108 healthy adults randomly assigned to receive 10, 100, or 300 mg of BBG2Na in aluminum phosphate or saline placebo. Each subject received 1, 2, or 3 intramus-cular injections of the...

  • ERRATUM.  // Journal of Infectious Diseases;2/1/2012, Vol. 205 Issue 3, p520 

    A correction to the article ''Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice" by Fu-Shi Quan and colleagues that was published in a previous issue of the periodical is presented.

  • Serum Neutralizing Antibody Titers of Seropositive Chimpanzees Immunized with Vaccines... Hancock, Gerald E.; Smith, Jason D.; Heers, Kristen M. // Journal of Infectious Diseases;5/1/2000, Vol. 181 Issue 5, p1768 

    Evaluates the ability of subunit vaccines formulated with purified fusion proteins from the A2(PFP-2) or attenuated 248/404 (PFP-3) strains of respiratory syncytial virus (RSV) to augment serum neutralizing antibody titers in seropositive chimpanzees. Enhancement of serum neutralizing antibody...

  • journal club. also of note. FREEDMAN, MARIAN // Contemporary Pediatrics;Feb2016, Vol. 33 Issue 2, p12 

    This article discusses a study published in the "New England Journal of Medicine" in 2015, showing the effectiveness of the oral nucleoside analogue ALS-008176 against the respiratory syncytial virus (RSV).

  • RSV Infection – Not for Kids Only. Sethi, Sanjay; Murphy, Timothy F. // New England Journal of Medicine;4/28/2005, Vol. 352 Issue 17, p1810 

    The article presents the opinion of the authors on an article dealing with the respiratory syncytial virus (RSV) in this issue of the Journal. According to the authors, the article places the public health dimensions of RSV infection in adults in perspective. They say that infants and the...

  • Best anti-BRD plan begins before you buy. McDONALD, STEVE // Mid-South Farmer;Nov2012, Vol. 17 Issue 11, Special section p5 

    The article presents the author's insight regarding the mass treatment and right timing of giving antibiotics and vaccines to calves with bovine respiratory disease (BRD).

  • RSV F-Protein Vaccine Clinical Trial Yields Positive Top-Line Results.  // Journal of Gerontological Nursing;2015, Vol. 41 Issue 11, p6 

    The article discusses the results obtained by Novavax Inc. for its respiratory syncytial virus (RSV) F-protein recombinant nanoparticle vaccine. Topics included are the safety and immunogenicity indicated by top-line data from their Phase 2 clinical trial, the statistical validation of vaccine...

  • Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics. Murphy, Brian R.; Collins, Peter L. // Journal of Clinical Investigation;7/1/2002, Vol. 110 Issue 1, p21 

    Discusses the applications of reverse genetics to live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses. Molecular biology of respiratory syncytial virus and the human parainfluenza viruses; Genetic basis of attenuation in biologically derived, live-attenuated virus...

  • Antibody-Dependent Enhancement, a Possible Mechanism in Augmented Pulmonary Disease of Respiratory Syncytial Virus in the Bonnet Monkey Model. Ponnuraj, Esther M.; Springer, Jennifer; Hayward, Anthony R.; Wilson, Harry; Simoes, Eric A.F. // Journal of Infectious Diseases;4/15/2003, Vol. 187 Issue 8, p1257 

    Determines whether the formalin-inactivated (FI) respiratory syncytial virus (RSV) vaccine stimulates the production of enhancing antibodies that serve to increase the replication of RSV in macrophages in bonnet monkeys. Antibody-dependent enhancement in animals immunized with FI-RSV but not in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics